PDF herunterladen
Thromb Haemost 2004; 92(03): 621-626
DOI: 10.1160/TH04-01-0048
Platelets and Blood Cells
Schattauer GmbH

Platelet hyperreactivity in hemodialysis patients with frequently occluded vascular access

Kang-Ju Chou
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2   National Yang-Ming University, School of Medicine, Taipei, Taiwan
,
Chung-Ren Jan
3   Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung Taiwan
,
Po-Tsang Lee
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2   National Yang-Ming University, School of Medicine, Taipei, Taiwan
,
Chien-Liang Chen
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2   National Yang-Ming University, School of Medicine, Taipei, Taiwan
,
Hsiao-Min Chung
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2   National Yang-Ming University, School of Medicine, Taipei, Taiwan
,
Yueh-Yen Hwang
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
,
Jing-Dung Chou
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
,
Hua-Chang Fang
1   Division of Nephrology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
2   National Yang-Ming University, School of Medicine, Taipei, Taiwan
› InstitutsangabenFinancial support: This work was supported by grants from the National Science Council (NSC89-2320-B-075B-015) and Kaohsiung Veterans General Hospital (VGHKS91-46) to Dr. Kang-Ju Chou and (VGHKS91-47) to Dr. Hua-Chang Fang.
Weitere Informationen

Publikationsverlauf

Received 26. Januar 2004

Accepted after revision 09. Mai 2004

Publikationsdatum:
30. November 2017 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

It is known that thrombosis is a leading cause of vascular access failure and that the formation of thrombus requires platelets. The activation of platelets induces the increase in intracellular Ca2+ levels ([Ca2+]i) leading to aggregation and thrombosis. We compared the platelet [Ca2+]i before and after stimulation between the patients with and without easily occluded vascular access. Our study included two groups of hemodialysis patients. Group 1 consisted of 21 patients who had received chronic hemodialysis therapy for more than 6 months. They had had more than three events (including three) of vascular access failures during the past year. Group 2 consisted of 21 hemodialysis patients with age, sex, and diabetes mellitus matched who had never suffered from any event of vascular access failure. We measured the basal and stimulated platelet [Ca2+]i after stimulation with 1 U/ml thrombin, 1 µM arachidonic acid, 1 µM platelet activation factor (PAF), and 10 µM adenosine diphosphate (ADP), respectively. Our results showed that in Ca2+-containing media, there was no significant differences in the basal [Ca2+]i , but the maximal increases of [Ca2+]i of platelets were higher (p <0.05) in group 1 than in group 2 after stimulating with PAF and ADP, but not with thrombin and arachidonic acid. We concluded that the causes for the susceptibility of some hemodialysis patients to vascular access occlusion were multifactorial. In addition to previously reported plasma factors, there was a subgroup of patients who showed greater elevations of agonists stimulated platelet intracellular calcium levels.

Keywords

Agonists - hemodialysis - intracellular calcium - platelet - vascular access failure
 

  • References

  • 1 Fan PY, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol 1992; 03: 1-11.
    PubMedGoogle Scholar
  • 2 Windus DW. Permanent vascular access: a nephrologist’s view. Am J Kidney Dis 1993; 21: 457-71.
    CrossrefPubMedGoogle Scholar
  • 3 Porile JL, Richter M. Preservation of vascular access. J Am Soc Nephrol 1993; 04: 997-1003.
    PubMedGoogle Scholar
  • 4 Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 07: 523-35.
    PubMedGoogle Scholar
  • 5 Mysliwiec M. Vascular access thrombosiswhat are the possibilities of intervention?. Nephrol Dial Transplant 1997; 12: 876-78.
    CrossrefPubMedGoogle Scholar
  • 6 Massini P, Luscher EF. On the significance of the influx of calcium ions into stimulated human blood platelets. Biochim Biophys Acta 1976; 436: 652-63.
    CrossrefPubMedGoogle Scholar
  • 7 Massini P, Kaser-Glanzmann R, Luscher EF. Movement of calcium ions and their role in the activation of platelets. Thromb Haemost 1978; 40: 212-8.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 8 Feinstein MB. Role of Ca2+-ions in the regulation of platelet function. Bibl Haematol 1978; 45: 1-8.
    PubMedGoogle Scholar
  • 9 Steer ML, Salzman EW. Cyclic nucleotides in hemostasis and thrombosis. Adv Cyclic Nucleotide Res 1980; 12: 71-92.
    PubMedGoogle Scholar
  • 10 Feinstein MB. The role of calmodulin in hemostasis. Prog Hemost Thromb 1982; 06: 25-61.
    PubMedGoogle Scholar
  • 11 Zucker MB, Nachmias VT. Platelet activation. Arteriosclerosis 1985; 05: 2-18.
    CrossrefPubMedGoogle Scholar
  • 12 Rink TJ. Cytosolic calcium in platelet activation. Experientia 1988; 44: 97-100.
    CrossrefPubMedGoogle Scholar
  • 13 Dmoszynska-Giannopoulou A, Krawczyk W. The role of calcium ions and inositol phospholipids in platelet activation Acta Haematol Pol. 1991; 22: 336-45.
    PubMedGoogle Scholar
  • 14 Geiger J, Nolte C, Butt E. et al. Role of cGMP and cGMP-dependent protein kinase in nitrovasodilator inhibition of agonist-evoked calcium elevation in human platelets. Proc Natl Acad Sci U S A 1992; 89: 1031-5.
    CrossrefPubMedGoogle Scholar
  • 15 Jin J, Daniel JL, Kunapuli SP. Molecular Basis for ADP-induced Platelet Activation J Biol Chem. 1998; 273: 2030-4.
    PubMedGoogle Scholar
  • 16 Hussain JH, Mahaut-Smith MP. Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets. J Physiol 1999; 514: 713-8.
    CrossrefPubMedGoogle Scholar
  • 17 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
    PubMedGoogle Scholar
  • 18 De Marchi S, Falleti E, Giacomello R. et al. Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients. J Am Soc Nephrol 1996; 07: 1169-77.
    PubMedGoogle Scholar
  • 19 Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: Design synthesis and properties of prototype structures. Biochemistry 1980; 19: 2396-404.
    CrossrefPubMedGoogle Scholar
  • 20 Rink TJ, Smith SW, Tsien RY. Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca-independent activation for shapechange and secretion. FEBS Lett 1982; 148: 21-6.
    CrossrefPubMedGoogle Scholar
  • 21 Poenie M, Alderton J, Tsien RY. et al. Changes of free calcium levels with stages of the cell division cycle. Nature 1985; 315: 147-9.
    CrossrefPubMedGoogle Scholar
  • 22 Siess W. Molecular mechanisms of platelet activation. Physiological Reviews 1989; 69: 58-178.
    CrossrefPubMedGoogle Scholar
  • 23 Tao J, Rose B, Haynes DH. Variability of the thrombin-and ADP-induced Ca2+ response among human platelets measured using fluo-3 and fluorescent videomicroscopy. Biochim Biophys Acta 1996; 1311: 164-74.
    CrossrefPubMedGoogle Scholar
  • 24 Shukla SD. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J 1992; 06: 2296-301.
    CrossrefPubMedGoogle Scholar
  • 25 Logan JE, Roudebush WE. Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos. Early Pregnancy 2000; 04: 30-8.
    PubMedGoogle Scholar
  • 26 Brace LD, Venton DL, Le Breton GC. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets. Am J Physiol 1985; 249 1 Pt 2 H1-7.
    CrossrefPubMedGoogle Scholar
  • 27 Vu TK, Hung DT, Wheaton VI. et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991; 64: 1057-68.
    CrossrefPubMedGoogle Scholar
  • 28 Ishihara H, Connolly AJ, Zeng D. et al. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386: 502-6.
    CrossrefPubMedGoogle Scholar
  • 29 Xu WF, Andersen H, Foster DC. Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998; 95: 6642-6.
    CrossrefPubMedGoogle Scholar
  • 30 Parise LV, Venton DL, Le Breton GC. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction. J Pharmacol Exp Ther 1984; 228: 240-4.
    PubMedGoogle Scholar
  • 31 Ishii S, Nagase T, Shimizu T. Platelet-activating factor receptor. Prostaglandins Other Lipid Mediat 2002; 68-69: 599-609.
    CrossrefPubMedGoogle Scholar
  • 32 MacKenzie AB, Mahaut-Smith MP, Sage SO. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 1996; 271: 2879-81.
    CrossrefPubMedGoogle Scholar
  • 33 Daniel JL, Dangelmaier C, Jin J. et al. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
    CrossrefPubMedGoogle Scholar
  • 34 Schaberg T, Haller H, Lode H. Evidence for a platelet-activating factor receptor on human alveolar macrophages. Biochem Biophys Res Commun 1991; 177: 704-10.
    CrossrefPubMedGoogle Scholar
  • 35 Nomura S. Function and clinical significance of platelet-derived microparticles. Int J Hematol 2001; 74: 397-404.
    CrossrefPubMedGoogle Scholar
  • 36 Dopheide SM, Yap CL, Jackson SP. Dynamic aspects of platelet adhesion under flow. Clin Exp Pharmacol Physiol 2001; 28: 355-63.
    CrossrefPubMedGoogle Scholar